Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Heart Lung Circ ; 25(3): 282-9, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26672437

RESUMO

BACKGROUND: Transcatheter aortic valve replacement (TAVR) patients are at a high risk of acute kidney injury (AKI). This study aimed to investigate AKI and the relationship with iodinated contrast media (ICM), whether there are significant pre- or peri- procedural variables predicting AKI, and whether AKI impacts on hospital length of stay and mortality. METHODS: Serum creatinine (SC) levels pre- and post- (peak) TAVR were recorded in 209 consecutive TAVR patients. AKI was defined by the Valve Academic Research Consortium 2 (VARC2) criteria. Baseline characteristics, procedural variables, hospital length of stay (LOS) and mortality at 72hours, 30 days and one year were analysed. RESULTS: Eighty-two of 209 (39%) patients suffered AKI. Mean ICM volume was 228cc, with no difference between patients with AKI and those with no AKI (227cc (213-240(95%CI)) vs 231cc (212-250) p=0.700)). Univariate and multivariate analysis demonstrated that chronic kidney disease, respiratory failure, previous stroke, the need for blood transfusion and valve repositioning were all predictors of AKI. Acute kidney injury increased LOS (5.6 days (3.8 - 7.5) vs 3.2 days (2.6 - 3.9) no AKI (P=0.004)) but was not linked to increased mortality. Mortality rates did increase with AKI severity. CONCLUSION: Acute kidney injury is a common complication of TAVR. The severity of AKI is important in determining mortality. Acute kidney injury appears to be independent of ICM use but pre-existing renal impairment and respiratory failure were predictors for AKI. Transcatheter aortic valve replacement device repositioning or retrieval was identified as a new risk factor impacting on AKI.


Assuntos
Injúria Renal Aguda/mortalidade , Complicações Pós-Operatórias/mortalidade , Substituição da Valva Aórtica Transcateter/efeitos adversos , Injúria Renal Aguda/sangue , Injúria Renal Aguda/etiologia , Idoso de 80 Anos ou mais , Creatinina/sangue , Feminino , Humanos , Masculino , Complicações Pós-Operatórias/sangue , Fatores de Risco
2.
J Med Radiat Sci ; 66(1): 20-29, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30488575

RESUMO

INTRODUCTION: Diagnostic coronary angiography (CA) uses ionising radiation with relatively high doses, which impact on both patients and staff. This study sought to identify which patient and procedural factors impact patient and operator dose the most during CA. METHODS: Patient and procedure related variables impacting on Kerma area product (PKA ) and operator dose (OD) were collected for 16 months. Procedures were separated into 10 different procedure categories. PKA was used for patient dose and OD was measured with an instantly downloadable dosimeter (IDD) - downloaded at the end of each procedure. High and low radiation dose was defined by binary variables based on the 75th percentile of the continuous measures. Univariate and multivariate regression were used to identify predictors. RESULTS: Of 3860 patients included, the IDD was worn for 2591 (61.7%). Obesity (BMI > 30 compared to BMI < 25) was the strongest predictor for both a PKA (odds ratio (OR) = 19.1 (95% CI 13.5-26.9) P < 0.001) and OD (OR = 3.3 (2.4-4.4) P < 0.001) above the 75th percentile. Male gender, biplane imaging, the X-ray unit used, operator experience and procedure type also predicted a high PKA . Radial access, male gender, biplane imaging and procedure type also predicted a high OD. CONCLUSION: Radiation dose during CA is multifactorial and is dependent on patient and procedure related variables. Many factors impact on both PKA and OD but obesity is the strongest predictor for both patients and operators to receive a high radiation dose.


Assuntos
Angiografia Coronária , Exposição Ocupacional/análise , Doses de Radiação , Exposição à Radiação/análise , Idoso , Angiografia Coronária/efeitos adversos , Feminino , Humanos , Masculino , Proteção Radiológica , Estudos Retrospectivos
3.
J Invasive Cardiol ; 25(3): E48-50, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23468452

RESUMO

Very-late stent thrombosis is a rare complication. Several factors related to the patient, procedure, and premature discontinuation of antiplatelet therapy are known to contribute to its occurrence. This report describes the case of a 40-year-old patient with simultaneous two-vessel stent thrombosis (left anterior descending and right coronary arteries) 31 months after everolimus-eluting stent implantation.


Assuntos
Aspirina/uso terapêutico , Trombose Coronária/diagnóstico , Stents Farmacológicos , Cooperação do Paciente , Inibidores da Agregação Plaquetária/uso terapêutico , Sirolimo/análogos & derivados , Adulto , Angioplastia Coronária com Balão , Trombose Coronária/etiologia , Trombose Coronária/terapia , Eletrocardiografia , Everolimo , Humanos , Masculino , Infarto do Miocárdio/fisiopatologia , Infarto do Miocárdio/terapia , Intervenção Coronária Percutânea/métodos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA